Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

Experimental models of Rett syndrome based on Mecp2 dysfunction.

Gaston Calfa1, Alan K Percy, Lucas Pozzo-Miller

  • 1Department of Neurobiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Experimental Biology and Medicine (Maywood, N.J.)
|January 18, 2011
PubMed
Summary

Rett syndrome, a neurodevelopmental disorder caused by MECP2 gene mutations, shows potential for new therapies. Mouse models reveal how Mecp2 loss impacts brain function, offering hope for symptom reversal in individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined maternal separation and limited bedding-nesting increase goal tracking, delay discounting, and impulsive action, and moderate sign-tracking-perseverance associations in male rats.

BMC neuroscience·2026
Same author

MeCP2 is Necessary in Cerebellar Purkinje Cells for Precise Network Dynamics During Associative Motor Learning.

bioRxiv : the preprint server for biology·2026
Same author

Atypical social behaviors in mouse models for Rett syndrome.

Frontiers in neurology·2026
Same author

mPFC pyramidal neuron synchrony during social competition to form social rankings is disrupted in male Mecp2 knockout mice.

bioRxiv : the preprint server for biology·2026
Same author

Trajectory of skill acquisition, loss, and regain in females with classic Rett syndrome.

Journal of neurodevelopmental disorders·2026
Same author

Multi-timescale Computation by Astrocytes.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Neuroscience
  • Genetics
  • Epigenetics

Background:

  • Rett syndrome (RTT) is a rare neurodevelopmental disorder affecting females, with an incidence of 1:10,000 births.
  • It is primarily caused by mutations in the MECP2 gene, which encodes methyl-CpG-binding protein-2 (MECP2), an epigenetic transcription factor.
  • Clinical presentation includes normal early development followed by regression, with symptoms often mistaken for autism.

Purpose of the Study:

  • To investigate the impact of MECP2 gene mutations on brain cell morphology, function, and network activity.
  • To explore the potential of experimental models for developing therapeutic strategies for Rett syndrome.

Main Methods:

  • Characterization of mouse models with loss-of-function mutations in the Mecp2 gene.
  • Analysis of subtle changes in brain cell and synapse morphology and function.

More Related Videos

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Related Experiment Videos

Last Updated: Jun 5, 2026

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

  • Evaluation of RTT-like symptoms in experimental models.

    • Main Results:

    • Loss of Mecp2 function in mouse models leads to significant alterations in brain cell and synapse morphology and function.
    • These cellular changes profoundly impact network activities crucial for brain function.
    • Experimental models demonstrated successful reversal of RTT-like symptoms through various manipulations.

    Conclusions:

    • MECP2 gene mutations have profound consequences on neural network activity underlying critical brain functions.
    • Experimental models provide a platform for testing and developing novel therapeutic strategies for Rett syndrome.
    • Successful symptom reversal in models offers hope for improving the quality of life for individuals with Rett syndrome.